Crowell & Moring LLP has added 23 new attorneys to the firm by acquiring a health care and labor and employment boutique, along with three intellectual property partners from another firm.
Specialty drug maker Spectrum Pharmaceuticals Inc. has settled a patent infringement suit with GlaxoSmithKline over the use of the migraine injection treatment Imitrex.
Yale University and a biochemistry professor have until the end of December to file a motion to dismiss a lawsuit brought a by a former scientist who says she hasn’t been paid royalties for a component of a blood test she helped invent.
A Quebec court has given its stamp of approval for the first personal-injury class action in North America against Merck & Co. over the painkiller Vioxx.
A federal court has dismissed Acumed LLC’s patent infringement suit against Stryker Corp. for litigating claims it could have raised in a prior action.
A month after upholding the validity and enforceability of a Johnson & Johnson unit’s patent for the antipsychotic drug Risperdal, a New Jersey district court has thrown out a slew of pending noninfringement and unfair competition counterclaims brought by two generics companies.
A unit of Shire PLC has renewed the company’s efforts to stave off a copycat version of its blockbuster hyperactivity drug Adderall nearly three months after Shire resolved a patent stand-off with Barr Laboratories Inc. over the same drug.
A blind six-year-old boy is $20 million wealthier after a Pennsylvania jury awarded him the hefty sum Thursday, concluding the hospital where he was born and his pediatrician’s office were negligent.
In a move that highlights the growing debate over the balance between the rights of poor nations and those of drug patent holders, a group of patients said on Friday it plans to intervene in Pfizer Inc.’s ongoing legal battle to protect its blockbuster hypertension treatment Norvasc in the Philippines.
In a bid to quell escalating concerns over medical device regulation, the U.S. Food and Drug Administration on Thursday jumped into action, revealing plans to bolster the way it monitors the safety of products such as stents, pacemakers, and implantable defibrillators after they reach the marketplace.
A federal judge has temporarily stopped famed crusader Erin Brockovich from pursuing her latest cause, dismissing a slew of suits that she recently filed in response to an alleged abuse of the Medicare system.
The U.S. Federal Trade Commission is probing an agreement between Barr Pharmaceuticals and Shire PLC that put to rest two patent lawsuits brought by Shire that sought to thwart Barr’s attempts to market a generic version of the hyperactivity drug Adderall XR.
The recent shift in power in Congress could bring big changes to the pharmaceutical industry, with Democrats already promising legislative change to make drugs more affordable for consumers.
Hospital Corporation of America Inc. agreed to settle a shareholder lawsuit on Wednesday, paving the way for a $21.3 billion buyout of the for-profit hospital chain by private equity group Hercules Holding II LLC.
Connetics Corp. was hit Wednesday with yet another securities class action lawsuit over allegations that it concealed information from its shareholders regarding the new acne drug Velac.
An appeals court panel has invalidated an Abbott Laboratories Inc. patent covering Ultane, thus solidifying rival pharmaceutical company Baxter International Inc.’s ability to sell a generic version of the popular inhaled anesthetic.
U.S. and Korean negotiators are struggling to bridge their differences in talks to amend South Korea’s regulatory regime for patented drugs, according to sources close to the negotiations.
A New Jersey couple has hit Aetna Inc. with a lawsuit, accusing the insurance giant of failing to fully cover their daughter’s treatment for anorexia.
A federal magistrate judge has ruled that reproductive rights advocates can have access to White House documents in a lawsuit over the U.S. Food and Drug Administration's handling of the morning-after pill.
Employees of insurance provider Cigna Healthcare of California Inc. filed a class action suit against the company Wednesday, claiming that as part of a work-at-home program they were denied overtime compensation and other employee benefits.